Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer Families

Abstract

Screening at-risk relatives from FPC families has a significant diagnostic yield, particularly in relatives >65 years of age, confirming prior studies. MRCP as initial screening modality is safe and effective.